**Core Concept**
The staging of ovarian cancer is based on the extent of tumor spread, with the **International Federation of Gynecology and Obstetrics (FIGO)** system being the most commonly used. The presence of **ascitic fluid** and **bilateral ovarian involvement** are key factors in determining the stage.

**Why the Correct Answer is Right**
Given the presence of **bilateral ovarian involvement** and **ascitic fluid**, this indicates that the cancer has spread beyond one ovary but has not necessarily spread to distant sites. The **FIGO staging system** classifies ovarian cancer based on surgical and pathological findings, and the presence of ascitic fluid can be associated with more advanced stages, but bilateral involvement without specified distant metastasis aligns with a specific stage.

**Why Each Wrong Option is Incorrect**
**Option A:** Is incorrect because it typically represents an earlier stage with less extensive disease.
**Option B:** Represents a stage with tumor limited to the ovaries, which does not match the given scenario of ascitic fluid.
**Option D:** Represents a stage with distant metastasis, which is not indicated by the information provided.

**Clinical Pearl / High-Yield Fact**
It's crucial to remember that the **FIGO staging system** for ovarian cancer is complex and takes into account various factors including the size and spread of the tumor, the presence of ascites, and whether the cancer has spread to lymph nodes or distant sites.

**Correct Answer:** C. Stage III